• Bonus or penalty? Medicare provider payments are now adjusted based on quality metrics

  By Christopher Kunkel, Mike Hamachek | 16 September 2019

  What happened in the first year of Merit-Based Incentive Payment System reporting?

• Use of real-world healthcare data to widen the evidence base

  By Joanne Buckle, Tanya Hayward | 09 September 2019

  This paper outlines some of the key considerations associated with using real-world data to widen the evidence base used in economic evaluations.

• Trust but verify: Best practices for third party validation in provider risk-sharing contracts

  By Colleen Norris, Thomas D. Snook | 27 August 2019

  While shared-risk contracts may be conceptually simple, the actual real-world financial adjudication of these contracts is usually complex.

• DRGs: Is this the next chapter for the Cyprus healthcare system?

  By Nicholas Kallis | 23 August 2019

  This article is the first part of a series of short articles about diagnosis-related groups systems.

• Early thoughts on the Primary Care First model

  By Raheel Sohail, Cory Gusland, Daniel Henry | 22 August 2019

  This paper explores key model features of the Center for Medicare and Medicaid Innovation’s Primary Care First, a new voluntary payment model focused on primary care.

• Impact of Mental Healthcare Act, 2017, on the Indian healthcare insurance industry

  By Joanne Buckle, Neha Taneja, Rachin Aggarwal, Vidhi Gupta | 20 August 2019

  This paper looks at the key provisions of the Mental Healthcare Act, 2017, mental illness prevalence, supply-side indicators and the current treatment gap.

• Combination products: An accelerated education

  By Robert Eaton | 20 August 2019

  Combination products provide valuable, and often substantial, health insurance coverage in the framework of a life insurance or annuity policy.

• A new Part D benefit design? Prescription Drug Pricing Reduction Act proposes major changes to Part D

  By Joanna Amend, Samantha J. D’Anna, Dustin J. Grzeskowiak, Justin Harris, Matthew Hayes | 15 August 2019

  This article provides an overview of the provisions in the Prescription Drug Pricing Reduction Act of 2019 and the effects on Medicare Part D stakeholders.

• Long-term care insurance valuation: An industry survey of assumptions and methodologies

  By Allen J. Schmitz, Tim F. Kempen | 01 August 2019

  This report presents the results of our sixth triennial long-term care insurance valuation survey.

• 2019 Milliman Medical Index

  By Christopher S. Girod, Susan K. Hart, David M. Liner, Thomas D. Snook, Scott A. Weltz | 25 July 2019

  In 2019, the cost of healthcare for a hypothetical American family of four covered by an average employer-sponsored preferred provider organization (PPO) plan is $28,386.

See More Articles